Colder BHO Extractions Yield Cleaner Cannabis Concentrates, Abstrax Study Finds

LOS ANGELES – Researchers at Abstrax Tech have found that colder extraction temperatures during butane hash oil (BHO) processing significantly reduce the carryover of plant-derived wax compounds into finished concentrates, without meaningfully affecting cannabinoid potency or terpene retention. The findings appear in a peer-reviewed paper published in ACS Omega.

The Abstrax research team, including R&D scientists, ran n-butane extractions of two Cannabis varieties, GMO and Oreoz, stored at −50°C to minimize degradation prior to processing. Extractions were conducted across an industrially relevant temperature range of −46°C to −9°C. Using comprehensive two-dimensional gas chromatography, the researchers identified long-chain n-alkanes in the carbon range C22–C31, consistent with epicuticular wax constituents, as major components whose abundance increases systematically with extraction temperature, while total cannabinoids and quantified volatile aroma compounds remain relatively constant over the same range.

The implications extend beyond the raw extract. In a secondary phase, Abstrax measured what happens to these alkanes during vaporization. Aerosol capture experiments demonstrate that these n-alkanes transfer efficiently into the mainstream aerosol and that aerosol wax levels track their concentrations in the starting high-terpene extract with an approximately linear relationship. Colder extraction thus translates directly into a reduced wax dose for the consumer. Lowering the extraction temperature reduces both wax content in the oil and the corresponding wax dose in the aerosol, with up to approximately three-fold reductions based on cultivar.

The study acknowledges that the molecular identity of this wax fraction in hydrocarbon extracts had been poorly defined prior to this work, and quantitative data linking extraction process variables to final wax concentration were similarly underexplored. Abstrax conducted the experimental work at its Type 7 licensed Tustin laboratory, and the findings connect directly to the company’s broader RA-TEP inhalation toxicology program for cannabis vape safety evaluation.

For extract producers, the paper identifies a straightforward lever: lowering solvent temperature during extraction reduces wax co-extraction by a measurable margin without compromising the cannabinoid and terpene profiles that define product quality. No new hardware is required. The adjustment sits within existing closed-loop systems. These results establish extraction temperature as a practical control point for minimizing epicuticular wax coextraction in hydrocarbon-derived cannabis concentrates, demonstrating that lower temperatures selectively reduce long-chain n-alkane content while preserving cannabinoid potency and native-like aroma profiles.

This study draws a direct line from process variable to consumer aerosol composition, a connection the concentrate sector had not formally established in peer-reviewed literature. For operators in a market where vape accounts for roughly a quarter of total U.S. Cannabis retail sales, and where regulatory scrutiny of inhalation products continues to tighten, the finding that a single temperature adjustment can cut wax delivery to consumers by up to three times is precisely the kind of data that separates process-disciplined producers from those still operating on undocumented practice.